Open access
Jul 2026
Inhibition of HIV-1 cell-to-cell transmission in-vitro using engineered CAR NK/T cells 2253162
Evidence is provided that targeting HIV-1 C-CT through ADCC and CAR NK/T cell therapies can overcome the limitations of bnAbs, and the first evidence to test these approaches to effectively target HIV-1 C-CT is offered.
Tanvi Mathur, D. Mazurov, Alon Herschhorn
· Journal of Immunology · 0 citations